VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 51 of Oncotarget features Figure 5, "CAD and POLD2 association with chemotherapy response in bladder cancer patients," by
Givechian, et al.
Table of Contents
Research Papers
|
| Polymorphisms in DNA mismatch repair pathway genes predict toxicity and response to cisplatin chemoradiation in head and neck squamous cell carcinoma patients |
|
https://doi.org/10.18632/oncotarget.25268
|
| 29538-29547 |
|
| Genetic landscape of long noncoding RNA lncRNAs in glioblastoma: identification of complex lncRNA regulatory networks and clinically relevant lncRNAs in glioblastoma |
|
https://doi.org/10.18632/oncotarget.25434
|
| 29548-29564 |
|
| Phosphatidylinositol 3kinase p110δ expression in Merkel cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25619
|
| 29565-29573 |
|
| Fibrosis in metastatic lymph nodes is clinically correlated to poor prognosis in colorectal cancer |
|
https://doi.org/10.18632/oncotarget.25636
|
| 29574-29586 |
|
| Inhibition of mTOR downregulates expression of DNA repair proteins and is highly efficient against BRCA2mutated breast cancer in combination to PARP inhibition |
|
https://doi.org/10.18632/oncotarget.25640
|
| 29587-29600 |
|
| LMO1 functions as an oncogene by regulating TTK expression and correlates with neuroendocrine differentiation of lung cancer |
|
https://doi.org/10.18632/oncotarget.25642
|
| 29601-29618 |
|
| PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I1 in human breast cancer SKBR3 cells |
|
https://doi.org/10.18632/oncotarget.25651
|
| 29619-29633 |
|
| TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent Englerin A |
|
https://doi.org/10.18632/oncotarget.25659
|
| 29634-29643 |
|
| Polymorphism of regulatory region of APEH gene c521G>C rs4855883 as a relevant predictive factor for radiotherapy induced oral mucositis and overall survival in head neck cancer patients |
|
https://doi.org/10.18632/oncotarget.25662
|
| 29644-29653 |
|
| RET fusions observed in lung and colorectal cancers are sensitive to ponatinib |
|
https://doi.org/10.18632/oncotarget.25664
|
| 29654-29664 |
|
| KLF5 controls glutathione metabolism to suppress p190BCRABL+ Bcell lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.25667
|
| 29665-29679 |
|
| A CARP1 functional mimetic compound is synergistic with BRAFtargeting in nonsmall cell lung cancers |
|
https://doi.org/10.18632/oncotarget.25671
|
| 29680-29697 |
|
| Suppression of stress induction of the 78kilodalton glucose regulated protein GRP78 in cancer by IT139 an antitumor ruthenium small molecule inhibitor |
|
https://doi.org/10.18632/oncotarget.25679
|
| 29698-29714 |
|
| TIE2expressing monocytes and M2polarized macrophages impact survival and correlate with angiogenesis in adenocarcinoma of the pancreas |
|
https://doi.org/10.18632/oncotarget.25690
|
| 29715-29726 |
|
| MGMT inhibition in ER positive breast cancer leads to CDC2 TOP2A AURKB CDC20 KIF20A Cyclin A2 Cyclin B2 Cyclin D1 ERα and Survivin inhibition and enhances response to temozolomide |
|
https://doi.org/10.18632/oncotarget.25696
|
| 29727-29742 |
|
| CAD/POLD2 gene expression is associated with poor overall survival and chemoresistance in bladder urothelial carcinoma |
|
https://doi.org/10.18632/oncotarget.25701
|
| 29743-29752 |
|
| MYCrelated microRNAs signatures in nonHodgkin Bcell lymphomas and their relationships with core cellular pathways |
|
https://doi.org/10.18632/oncotarget.25707
|
| 29753-29771 |
|
| TRAF3IP2 a novel therapeutic target in glioblastoma multiforme |
|
https://doi.org/10.18632/oncotarget.25710
|
| 29772-29788 |
|
| <i>GSTP1</i> rs1695 is associated with both hematological toxicity and prognosis of ovarian cancer treated with paclitaxel plus carboplatin combination chemotherapy: a comprehensive analysis using targeted resequencing of 100 pharmacogenes |
|
https://doi.org/10.18632/oncotarget.25712
|
| 29789-29800 |
|
| Secondline chemotherapy for the treatment of metastatic pancreatic cancer after firstline gemcitabinebased chemotherapy: a network metaanalysis |
|
https://doi.org/10.18632/oncotarget.25639
|
| 29801-29809 |
Clinical Research Papers
|
| Postoperative empyema following lung cancer surgery |
|
https://doi.org/10.18632/oncotarget.25629
|
| 29810-29819 |
Reviews
|
| Systematic literature review of IL6 as a biomarker or treatment target in patients with gastric bile duct pancreatic and colorectal cancer |
|
https://doi.org/10.18632/oncotarget.25661
|
| 29820-29841 |
Corrections
|
| Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25759
|
| 29842-29842 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
